Diabetes Mellitus, Type 2

• Novo Nordisk Investigational Site — Miami, Florida, United States
• Novo Nordisk Investigational Site — Orlando, Florida, United States
• Novo Nordisk Investigational Site — Knoxville, Tennessee, United States

• Veronica Atkins Lifestyle Intervention Laboratory — Los Angeles, California, United States

• Veronica Atkins Lifestyle Intervention Laboratory — Los Angeles, California, United States

• Novo Nordisk Investigational Site — Shatin, New Territories, Hong Kong
• Novo Nordisk Investigational Site — Chuo-ku, Tokyo, Japan
• Novo Nordisk Investigational Site — Kamakura-shi, Kanagawa, Japan
• Novo Nordisk Investigational Site — Kawasaki-shi, Japan

• Carl T. Hayden VA Medical Center — Phoenix, Arizona, United States
• Southern Arizona VA Health Care System, Tucson — Tucson, Arizona, United States
• VA Central California Health Care System, Fresno — Fresno, California, United States
• VA Medical Center, Long Beach — Long Beach, California, United States

Not specified

Not specified

• Pharmatelligence — Cardiff, United Kingdom

• Optum Epidemiology — Boston, Massachusetts, United States

Not specified